Focus on the Use of Resveratrol in Bladder Cancer.
angiogenesis
apoptosis
bladder cancer
proliferation
resveratrol
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
26 Feb 2023
26 Feb 2023
Historique:
received:
17
01
2023
revised:
13
02
2023
accepted:
21
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
15
3
2023
Statut:
epublish
Résumé
Bladder cancer is the most common tumor of the urinary system, with a high incidence in the male population. Surgery and intravesical instillations can eradicate it, although recurrences are very common, with possible progression. For this reason, adjuvant therapy should be considered in all patients. Resveratrol displays a biphasic dose response both in vitro and in vivo (intravesical application) with an antiproliferative effect at high concentrations and antiangiogenic action in vivo (intraperitoneal application) at a low concentration, suggesting a potential role for it in clinical management as an adjuvant to conventional therapy. In this review, we examine the standard therapeutical approach to bladder cancer and the preclinical studies that have investigated resveratrol in xenotransplantation models of bladder cancer. Molecular signals are also discussed, with a particular focus on the STAT3 pathway and angiogenic growth factor modulation.
Identifiants
pubmed: 36901993
pii: ijms24054562
doi: 10.3390/ijms24054562
pmc: PMC10003096
pii:
doi:
Substances chimiques
Resveratrol
Q369O8926L
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Antioxidants (Basel). 2022 May 30;11(6):
pubmed: 35739982
Drug Deliv. 2020 Dec;27(1):81-90
pubmed: 31858857
Nature. 2006 Nov 16;444(7117):337-42
pubmed: 17086191
Chemotherapy. 2010;56(1):60-5
pubmed: 20299793
Nanomedicine (Lond). 2019 Nov;14(21):2853-2871
pubmed: 31752574
Acta Biochim Pol. 2021 Oct 25;68(4):725-732
pubmed: 34694765
Mol Cells. 2016 Feb;39(2):87-95
pubmed: 26831453
Eur Urol. 2009 Aug;56(2):247-56
pubmed: 19409692
Mol Nutr Food Res. 2005 May;49(5):472-81
pubmed: 15779070
Nutrients. 2017 Dec 12;9(12):
pubmed: 29231856
Genet Mol Biol. 2021 Mar 22;44(1):e20200371
pubmed: 33749701
Cancer Lett. 2021 Sep 1;515:63-72
pubmed: 34052324
J Urol. 1996 Apr;155(4):1233-8
pubmed: 8632538
Scand J Urol Nephrol Suppl. 2008 Sep;(218):95-109
pubmed: 18815924
Anticancer Drugs. 2022 Jan 1;33(1):e389-e397
pubmed: 34486536
Arch Biochem Biophys. 2012 Nov 15;527(2):67-73
pubmed: 22750234
J Pharm Pharmacol. 2006 Apr;58(4):469-79
pubmed: 16597364
Int J Oncol. 2020 Jan;56(1):151-164
pubmed: 31814034
BJU Int. 2001 Aug;88(3):209-16
pubmed: 11488731
Int J Mol Sci. 2021 Sep 21;22(18):
pubmed: 34576315
Foods. 2020 Mar 14;9(3):
pubmed: 32183376
Oxid Med Cell Longev. 2021 Jul 11;2021:9932218
pubmed: 34336123
J Urol. 2003 Jan;169(1):90-5
pubmed: 12478111
Exp Ther Med. 2016 Jan;11(1):164-170
pubmed: 26889234
Int J Urol. 2012 Aug;19(8):757-64
pubmed: 22607368
Int J Biochem Cell Biol. 2009 Nov;41(11):2125-8
pubmed: 19527796
Int J Sport Nutr Exerc Metab. 2014 Feb;24(1):2-13
pubmed: 23918588
Cancer Manag Res. 2019 May 21;11:4631-4642
pubmed: 31191024
J Agric Food Chem. 2005 Feb 9;53(3):798-803
pubmed: 15686436
Nature. 2009 Apr 23;458(7241):1056-60
pubmed: 19262508
Nat Rev Drug Discov. 2006 Jun;5(6):493-506
pubmed: 16732220
Cancer Res. 2009 Sep 15;69(18):7449-58
pubmed: 19738051
Mol Biol Cell. 2005 Oct;16(10):4623-35
pubmed: 16079181
Mediators Inflamm. 2022 Aug 12;2022:7138756
pubmed: 35990040
J Agric Food Chem. 2011 May 11;59(9):4979-86
pubmed: 21401048
Eur Urol. 2013 Sep;64(3):421-30
pubmed: 23830475
Oncotarget. 2017 Jun 20;8(25):40289-40304
pubmed: 28178690
J Agric Food Chem. 1999 Apr;47(4):1533-6
pubmed: 10564012
Environ Mol Mutagen. 2019 Oct;60(8):740-751
pubmed: 31095781
Cancer Sci. 2010 Feb;101(2):488-93
pubmed: 20028382
Int J Mol Sci. 2017 Dec 01;18(12):
pubmed: 29194365
Front Nutr. 2020 Nov 13;7:570047
pubmed: 34422874
Mol Med Rep. 2014 Apr;9(4):1467-73
pubmed: 24535223
J Vet Sci. 2014;15(2):179-85
pubmed: 24675832
Urology. 2008 Sep;72(3):613-6
pubmed: 18554696
J Cell Physiol. 2017 Feb;232(2):436-446
pubmed: 27225870
J Urol. 1977 May;117(5):583-90
pubmed: 859200
Analyst. 2019 Mar 21;144(6):2062-2079
pubmed: 30724915
Curr Res Food Sci. 2020 Nov 24;3:284-295
pubmed: 33305295
Xenobiotica. 2005 Dec;35(12):1101-19
pubmed: 16418064
Scand J Urol. 2021 Aug;55(4):263-267
pubmed: 34037496
Biomolecules. 2020 Jan 19;10(1):
pubmed: 31963897
Int J Mol Sci. 2018 Sep 18;19(9):
pubmed: 30231546
Clin Cancer Res. 2004 Mar 15;10(6):2190-202
pubmed: 15041740
Eur Urol. 2013 Feb;63(2):234-41
pubmed: 22877502
J Urol. 2004 Jun;171(6 Pt 1):2186-90, quiz 2435
pubmed: 15126782
J Urol. 2007 Apr;177(4):1283-6; discussion 1286
pubmed: 17382713
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14178-82
pubmed: 11106374
Mol Med Rep. 2017 Mar;15(3):1179-1187
pubmed: 28098863
Cold Spring Harb Symp Quant Biol. 2011;76:81-90
pubmed: 22114328
Cancer Res. 2010 Nov 15;70(22):9003-11
pubmed: 20935227
Nutrients. 2018 Dec 05;10(12):
pubmed: 30563110
Virchows Arch. 2015 May;466(5):589-94
pubmed: 25697540
Eur Urol. 2021 Apr;79(4):480-488
pubmed: 33419683
Nutrients. 2019 Jan 11;11(1):
pubmed: 30641865
Sci Rep. 2019 Dec 5;9(1):18424
pubmed: 31804494
Fundam Clin Pharmacol. 2022 Jun;36(3):468-485
pubmed: 34935193
Urology. 2006 Jun;67(6):1216-23
pubmed: 16765182
Drug Metab Dispos. 2004 Dec;32(12):1377-82
pubmed: 15333514
Pharm Dev Technol. 2020 Mar;25(3):300-307
pubmed: 31609159
Drug Deliv Transl Res. 2017 Jun;7(3):395-407
pubmed: 28194730
Int J Oncol. 2012 Apr;40(4):1277-84
pubmed: 22200740
BJU Int. 2004 Mar;93(4):485-90
pubmed: 15008714
Biosci Rep. 2019 May 10;39(5):
pubmed: 30996115
PLoS One. 2014 Feb 25;9(2):e89806
pubmed: 24587049
Maturitas. 2012 May;72(1):72-8
pubmed: 22386766
Mol Neurobiol. 2022 Jul;59(7):4384-4404
pubmed: 35545730
Curr Drug Targets. 2006 Apr;7(4):423-42
pubmed: 16611030
Int J Mol Sci. 2019 Mar 19;20(6):
pubmed: 30893846
J Control Release. 2012 Mar 10;158(2):182-93
pubmed: 21978644
Eur J Pharm Sci. 2019 Sep 1;137:105011
pubmed: 31330260
Cell Metab. 2012 May 2;15(5):675-90
pubmed: 22560220
Mol Nutr Food Res. 2018 May;62(9):e1701057
pubmed: 29534330
Biofactors. 2018 Jan;44(1):16-25
pubmed: 29315886
Eur Urol. 2002 May;41(5):523-31
pubmed: 12074794
PLoS Med. 2007 Mar;4(3):e76
pubmed: 17341128
J Immunol. 2000 Jun 15;164(12):6509-19
pubmed: 10843709
Am J Clin Nutr. 2013 Feb;97(2):295-309
pubmed: 23283496
Am Fam Physician. 2009 Oct 1;80(7):717-23
pubmed: 19817342
Kaohsiung J Med Sci. 2021 Feb;37(2):128-135
pubmed: 33280258
Genes Dev. 1995 Dec 1;9(23):2888-902
pubmed: 7498786
Eur Urol. 2016 Feb;69(2):231-44
pubmed: 26091833
Histopathology. 2016 Dec;69(6):993-999
pubmed: 27383043
Eur Urol. 2007 Apr;51(4):889-97; discussion 897-8
pubmed: 17095142
J Biol Chem. 2002 May 24;277(21):18535-44
pubmed: 11893743
J Biol Chem. 2008 Jul 18;283(29):20015-26
pubmed: 18482975
Pharm Res. 2002 Dec;19(12):1907-14
pubmed: 12523673
Oncol Lett. 2019 Dec;18(6):6869-6876
pubmed: 31807190
J Natl Compr Canc Netw. 2013 Apr 1;11(4):477-84
pubmed: 23584348
Mol Nutr Food Res. 2009 May;53 Suppl 1:S7-15
pubmed: 19194969